A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Clinical trial NCT04255433 · COMPLETED
Trial details
- NCT number
- NCT04255433
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2025-06-12
- Enrollment
- 13299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.